Clinical Trials · NCT03439709
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Samsung Medical Center
- Enrollment
- 90
- Start date
- Mar 2018
- Locations
- 1 site, South Korea
- Primary endpoint
- endocrinologic remission